| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_474e284e10e4cc7ffe566f2ca951b1d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
| filingDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04044904fa5be909a50f3910cf84bea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd47bd98789530c9f895dc68ca4f19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841a1e311411acd8cac8eb546e2a02ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f642d1036eb93f68ad2ed8fe4ce790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_271d72fb49a094d3224162bc33b419ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ac8db3af931633ba12772a27d4316c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57b77bc28ab650aa45120874e60c70e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c9bee540da6d5478d6ff94bd7415495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413325fc8285e43854d0abce21ba86ad |
| publicationDate |
2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2269624-A2 |
| titleOfInvention |
Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| abstract |
The invention relates to a composition comprising at least two protective proteins against Streptococcus agalactiae (S. agalactiae) or functionally active variant thereof; a protective peptide against S. agalactiae; one or more nucleic acid(s) encoding the at least two proteins and/or the protective peptide; a method of producing the composition; a pharmaceutical composition, especially a vaccine, comprising the composition and/or at least one protective peptide; methods for producing antibodies; a mixture of antibodies against the at least two proteins of the composition; the use of the composition and/or at least one protective peptide and/or one or more nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; methods of diagnosing a S. agalactiae infection; a method for identifying a ligand capable of binding the composition and/or at least one protective peptide; and the use of the composition and/or at least one protective peptide for the isolation and/or purification and/or identification of an interaction partner of the composition and/or peptide. |
| priorityDate |
2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |